Under 60 and doing well
Keep going, reviewed yearlyNo arbitrary stopping point
The decision to continue is a yearly review of benefits and risks, not a countdown.
The yearly reviewHow Long Can You Stay on HRT?
There is no five-year limit on hormone therapy and no age at which it must stop. That rule came from the way the 2002 Women's Health Initiative results were reported, and it was never a guideline. The Menopause Society and ACOG say duration is individual and should be reviewed each year against whether symptoms persist, your risks at your current age and your goals. Some women take hormone therapy for two years; some for twenty. After 60, and with more years on treatment, the balance of benefit and risk changes.
Where are you with hormone therapy?
Pick what fitsPick what fits to see what the guidelines say.
Over 60, still having hot flashes
Continue, with adjustmentsTransdermal, lowest dose
Continuing after 60 for persistent hot flashes is reasonable. About a quarter of women still have flashes well into their sixties, and "wait it out" is poor advice when the wait is a decade.
What changes after 60Thinking of starting after 60
A specialist decision
Starting fresh after 60 or more than ten years past menopause is a specialist decision, because the cardiovascular evidence is less favourable for late starters. Local vaginal estrogen is fine to start at any age.
What changes after 60Told I've been on it long enough
Ask what changed
If your prescriber has told you to stop because you've "been on it long enough", ask what has changed in your risk profile.
What the guidelines sayReady to stop
Taper slowlyThree to six months
Trials find similar recurrence whether you stop abruptly or taper, but a taper is more comfortable and lets you see whether symptoms are returning at each step.
How to taperSymptoms came back after stopping
Restarting is reasonable
If symptoms return and life is worse, restarting is reasonable. This is not dependence; it is the return of the symptoms the hormones were treating.
If you want to stopMenopause came before 45
Continue to about 51Replacement, not treatment
Guidelines advise continuing at least until the average age of menopause, around 51, for bone, heart and brain health, and then making the ordinary yearly decision from there.
A different ruleSix things worth knowing.
- There is no five-year limit on hormone therapy and no age at which it must stop.
- The decision to continue is a yearly review of benefits and risks, not a countdown.
- After 60, transdermal estradiol and micronised progesterone become the default.
- A small increase in breast cancer risk comes with some combined regimens used beyond about five years.
- Tapering over three to six months is usually more comfortable than stopping suddenly.
- If menopause came before 45, guidelines advise continuing hormone therapy at least until around 51.
What the guidelines actually say
Three points, from The Menopause Society's 2022 position statement and ACOG's guidance.
- 1
No arbitrary stopping point
Neither a number of years nor an age. The decision to continue is a yearly review of benefits and risks, not a countdown.
- 2
The best time to start is early
Within ten years of menopause or before 60, which is what the FDA's updated labelling also recommends. Starting early and continuing is a different risk picture from starting late.
- 3
Continuing past 60 or 65 can be reasonable
When symptoms persist, quality of life depends on it, or bone protection is needed and alternatives don't suit, with shared decision-making, the lowest effective dose and usually a transdermal form.
The yearly review
Each year, with your prescriber, four questions.
Four questions, every year.
Do you still need it?
The honest test is a trial reduction. If symptoms return, you still need it; if they don't, you may be ready to taper.
What has changed in your risks?
A new diagnosis, a blood pressure drift, a family history update, a clot in a relative, a change in weight or smoking.
Is it the right form and dose?
Age pushes toward transdermal and toward the lowest dose that holds symptoms; see HRT dose adjustments and patch vs pill vs gel.
Is the screening up to date?
Mammography on schedule, blood pressure checked, any bleeding investigated. Bleeding after a settled pattern, at any point on treatment, needs evaluation; see bleeding after menopause.
What changes after 60
Age raises the baseline risk of clots, stroke and breast cancer for every woman, on hormones or not, so the same treatment carries a slightly larger absolute risk at 65 than at 52. That doesn't make it wrong; it changes the conversation.
At age
Starting fresh
Best time to startSpecialist decision
Starting fresh after 60 or more than ten years past menopause is a specialist decision, because the cardiovascular evidence is less favourable for late starters. Local vaginal estrogen is fine to start at any age.
Continuing
Yearly reviewReasonable for persistent flashes
Continuing after 60 for persistent hot flashes is reasonable. About a quarter of women still have flashes well into their sixties, and "wait it out" is poor advice when the wait is a decade.
The form
Reviewed each yearTransdermal by default
The form matters more. Transdermal estradiol, which doesn't raise clotting factors, and micronised progesterone, which carries less breast risk than older progestins, become the default.
Bone
Protected while on treatmentA bigger part of the decision
Bone becomes a bigger part of the decision. Hormone therapy prevents the bone loss that accelerates after menopause; for a woman with osteopenia who can't tolerate bone medications, that can be the reason to continue.
What accumulates with time, and what doesn't
Six things, over the years.
Breast cancer
- Changes with duration?
- Yes, small, with some combined regimens beyond about five years
- Notes
- Less with estrogen alone (after hysterectomy) and with micronised progesterone; the absolute increase is small and comparable to other lifestyle factors
Blood clots and stroke
- Changes with duration?
- Tied to age and route more than duration
- Notes
- Lower with transdermal; this is why forms are revisited with age
Endometrial cancer
- Changes with duration?
- Not if a progestogen is used correctly
- Notes
- Why the progestogen can't be skipped with a uterus
Gallbladder disease
- Changes with duration?
- Slightly higher with oral estrogen
- Notes
- Transdermal avoids it
Bone protection
- Changes with duration?
- Benefit continues while on treatment, fades after stopping
- Notes
- A reason some women continue
Hot flashes, sleep, mood, dryness
- Changes with duration?
- Benefit continues; symptoms often return when stopped
- Notes
- About half of women have flashes return
The BHRT guide covers the safety evidence and the FDA's 2025 labelling change in more detail.
If you want to stop
If you've decided to stop, these are the usual steps.
What a taper looks like.
- 1
Pick a quiet time
Not mid-winter if sweats were your issue, not during a stressful stretch.
- 2
Taper over three to six months
Trials find similar recurrence whether you stop abruptly or taper, but a taper is more comfortable and lets you see whether symptoms are returning at each step. Patches step down in strength; gel by the pump; pills by dose or alternate days under guidance. The progestogen stops when the estrogen does.
- 3
Expect some return
Around half of women get hot flashes back, which may be milder than before. Sleep and mood can wobble for a few weeks as levels settle.
- 4
Keep the local estrogen
Vaginal and bladder symptoms return when vaginal estrogen stops, and there's no reason to stop it; see vaginal dryness.
- 5
Have a plan for the symptoms
CBT, the sleep rules, and the non-hormonal prescriptions in who should not take HRT all work after stopping as well as instead of starting.
Early and premature menopause: a different rule
If menopause came before 45, and especially before 40, hormone therapy is replacement rather than treatment: it supplies what the body would have made until the usual age. Guidelines advise continuing at least until the average age of menopause, around 51, for bone, heart and brain health, and then making the ordinary yearly decision from there. See when menopause starts.
Two phases, not one.
How this works at Golden Leaf Health
Duration is part of every yearly review with your clinician: what's still needed, what's changed, whether the form and dose still fit your age and risks, and your goals. If you've been told to stop elsewhere without a reason, bring that question here.
Talk.
A one-on-one video visit about your symptoms, your history and what you want to feel like again. Your first visit is $99, refunded if you cancel at least 24 hours ahead.
Test.
If your provider thinks it will help, a hormone blood panel adds lab results to what you’ve told them. Not everyone needs this step.
Treat.
If treatment is right for you, your plan can include hormone prescriptions, non-hormonal options, lifestyle changes and optional supplements. Then two to three follow-up visits with a doctor and text check-ins through HIPAA-compliant messaging, included in membership at $49 a month, which begins one month after your first visit. Prescriptions and labs are priced separately.
Questions, answered plainly.
Is there a limit to how long you can take HRT?
No fixed limit. Current guidelines from The Menopause Society and ACOG say there is no arbitrary duration or age at which hormone therapy must stop. The decision is reviewed each year against your symptoms, your risks and your preferences.
Can you stay on HRT after 60 or 65?
Yes, if the benefits still outweigh the risks for you: persistent hot flashes, quality of life, or bone protection when other options don't suit. The usual conditions are a transdermal form, the lowest dose that works, and an informed yearly review. Local vaginal estrogen can continue at any age.
What are the risks of long-term HRT?
The ones that accumulate are a small increase in breast cancer risk with some combined regimens used beyond about five years, and clot and stroke risk that rises with age and is higher with oral estrogen. Estrogen-alone regimens and micronised progesterone carry less breast risk; transdermal forms carry less clot risk. Hormone therapy is not FDA-approved to prevent heart disease or dementia.
Should I taper off HRT or stop suddenly?
Trials show similar rates of symptoms returning either way, but tapering over three to six months is usually more comfortable and makes it easier to tell whether the symptoms are back. Talk to your prescriber before changing anything.
What if my symptoms come back after stopping HRT?
Symptoms return for about half of women. Restarting is a reasonable option, as are non-hormonal treatments, and the decision is the same yearly weighing of benefits and risks.
Talk through staying, adjusting or stopping.
A video visit with a clinician who treats perimenopause and menopause, in 33 states.
